NVision
NVision engineers molecular quantum systems for quantum-enhanced metabolic MRI and photonic-interfaced quantum computing.
- 148
- Private company
- Ulm, BW, DEGermany
NVision engineers molecular quantum systems for quantum-enhanced metabolic MRI and photonic-interfaced quantum computing.
NVision applies molecular engineering to magnetic-resonance hyperpolarization and quantum computing. Its POLARIS system is offered for preclinical research and uses room-temperature operation, while its clinical system and imaging agents remain investigational.
PIQC combines an optically addressable electron spin and nuclear-spin memory in engineered carbene molecules. NVision reports individual molecular-node demonstrations and describes thin-film integration with photonic chips as a development path, rather than a commercially available quantum computer.
Source: nvision-quantum.com
POLARIS is currently available for preclinical research. NVision says its clinical system remains in development and hyperpolarized imaging agents, including 13C pyruvate, have not received regulatory approval for routine clinical use. This limits currently evidenced use to research settings.
PIQC is at an earlier development stage. Published milestones describe individual molecular-qubit demonstrations, while the large-scale architecture remains a future objective. The route from molecule-level results to integrated, fault-tolerant systems remains unproven in the cited materials.
Source: nvision-quantum.com
NVision's current POLARIS offering serves preclinical magnetic-resonance research. The company makes that system available to researchers while continuing development of a clinical system and investigational imaging agents, so routine clinical use remains dependent on further development and regulatory review.
Its PIQC program addresses a separate quantum-computing development path. The official timeline identifies DLR demonstrator work and molecular-qubit milestones; those research activities do not establish existing sales of a large-scale quantum computer or cross-selling to imaging customers.
Source: nvision-quantum.com
NVision develops two molecular quantum platforms. POLARIS is a room-temperature hyperpolarizer offered for preclinical research; it amplifies the MRI signal of metabolites such as 13C-enriched pyruvate by more than 10,000 times. A clinical system and imaging agents remain investigational.
PIQC is a molecular quantum-computing architecture under development. NVision describes engineered carbene molecules that combine spin memory with an optical interface and are intended for integration with photonic chips. The company does not advertise PIQC as a product available for purchase.
Source: nvision-quantum.com